BetterLife Pharma Inc.
BETRF
$0.04
$0.00-3.05%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -294.80K | -359.90K | -148.80K | -517.70K | 440.60K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.50K | -54.70K | -159.60K | -394.40K | -419.50K |
| Change in Net Operating Assets | 245.70K | 289.20K | 298.40K | 898.60K | -125.20K |
| Cash from Operations | -8.60K | -125.40K | -10.00K | -13.50K | -104.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 25.00K | -- | 0.00 | 0.00 |
| Total Debt Repaid | -1.80K | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 150.00K | 25.00K | 8.70K | 34.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | -1.30K | 127.40K | 17.60K | 6.10K | 25.20K |
| Foreign Exchange rate Adjustments | -400.00 | 300.00 | 0.00 | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.20K | 2.30K | 7.60K | -7.40K | -78.80K |